OOIR: Observatory of International Research

Papers

(The H4-Index of European Neuropsychopharmacology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Route map for machine learning in psychiatry: Absence of bias, reproducibility, and utility	353
P.0012 The costs of alcohol hangover for the Dutch economy: impact of absenteeism and presenteeism	104
T58. EXPLORATION OF GENETIC AND CLINICAL HETEROGENEITY IN AUTISM BY CLUSTERING GENES BASED ON BULK AND SINGLE-CELL TRANSCRIPTOMIC DATA	93
Stress, mental disorder and ketamine as a novel, rapid acting treatment	91
F75. PREDICTION OF TREATMENT-RESISTANT SCHIZOPHRENIA USING REAL-WORLD DATA AND MULTIMODAL ANALYTICAL TOOLS	82
F7. THE ASSOCIATIONS BETWEEN EDUCATIONAL EXPERIENCES AND MENTAL HEALTH FROM CHILDHOOD TO YOUNG ADULTHOOD	69
41. CHARACTERIZING FUNCTIONAL CONVERGENCE OF COMMON POLYGENIC VARIATION IN NEUROPSYCHIATRIC DISORDER RISK GENES	69
F48. INVESTIGATING POTENTIAL RELATIONSHIPS BETWEEN PIGMENTATION GENETICS AND PARKINSON'S DISEASE (PD)	67
83. DAMAGING RARE CODING VARIANTS IDENTIFIED BY EXOME SEQUENCING ARE ASSOCIATED WITH REDUCED COGNITIVE FUNCTION IN SCHIZOPHRENIA	62
F94. SIGNIFICANT TELOMERE SHORTENING IN MALAYSIAN PATIENTS WITH SCHIZOPHRENIA: RELATIONSHIP WITH TOTAL ANTIOXIDANT CAPACITY AND OTHER COVARIATES	62
HOW PARTICIPATING IN CAMH'S PHARMACOGENETICS IMPACT STUDY CHANGED MY LIFE	58
GENETIC COUNSELING FOR PSYCHIATRIC CONDITIONS	56
85. DETECTION OF PLACENTAL SCHIZOPHRENIA RISK GENES	52
37. CONVERGENT IMPACT OF SCHIZOPHRENIA RISK GENES	52
8. A CROSS-POPULATION GENOME-WIDE ASSOCIATION STUDY OF SLEEP DURATION	51
6. DE NOVO MUTATIONS IN BIPOLAR DISORDER IMPLICATE GENES INVOLVED IN NEURODEVELOPMENT AND IMMUNITY	50
25. EPIGENOME-WIDE META-ANALYSIS OF > 3200 MILITARY AND CIVILIAN PARTICIPANTS IDENTIFIES CELL-TYPE SPECIFIC DNA METHYLATION SIGNALS ASSOCIATED WITH PTSD	48
DIFFERENTIAL ISOFORM USAGE IN SCHIZOPHRENIA	46
W87. RARE, PATHOGENIC COPY NUMBER VARIANTS CO-SEGREGATE WITH SCHIZOPHRENIA IN PEDIGREE COHORT	45
W64. FAMILY BASED ASSOCIATION AND LINKAGE ANALYSES OF FAMILIAL ADHD	45
W101. EPIGENETIC PROFILES OF LATENT CLASSES FOR POLYSUBSTANCE USE DISORDER	44
P.0016 Concomitant drug abuse in patients on methadone maintenance treatment	41
PUMAS: POPULATIONS UNDERREPRESENTED IN MENTAL ILLNESS ASSOCIATION STUDIES PROJECT	40
1. DEVELOPMENTAL TRAJECTORIES OF DNA METHYLATION IN NEURAL CELL POPULATIONS IN HUMAN CORTEX AND LINKS TO NEURODEVELOPMENTAL DISORDERS	39
TU90. STUDY OF GENETIC POLYMORPHISM AND DNA METHYLATION IN TUMOR NECROSIS FACTOR- ALPHA (TNF-Α) AND TRANSMEMBRANE 6 SUPERFAMILY MEMBER 2 (TM6SF2) IN ALCOHOL INDUCED LIVER CIRRHOSIS	37

2. ENRICHMENT OF RARE, DAMAGING VARIANTS IN SCHIZOPHRENIA-RELATED GENES IN INTELLECTUAL DISABILITY PATIENTS WITH PSYCHOTIC DISORDERS	37
W13. CLINICAL VALUE OF DIAGNOSTIC WHOLE GENOME/EXOME SEQUENCING IN FAMILIAL AUTISM SPECTRUM DISORDER	37
Society Calendar	35
ASSESSING THE EFFECTS OF RARE COPY NUMBER VARIANTS ON PSYCHIATRIC SYMPTOMS AND COGNITIVE ABILITY IN ∼1M INDIVIDUALS	35
W14. GENETIC CLUSTERING OF CO-OCCURRING SYMPTOMS IN PEOPLE WITH AUTISM: A MULTIVARIATE GENETIC VARIANCE ANALYSIS OF GENETIC RELATIONSHIP MATRICES IN THE SPARK SAMPLE	35
PHENOME-WIDE GENETIC CORRELATION AND CAUSALITY OF COVID-19 SEVERITY HIGHLIGHTS OVERLAP WITH SUBSTANCE-USE TRAITS	35
23. MASSIVELY PARALLEL, IN VIVO PROFILING OF MDD SNP EFFECTS ON TRANSCRIPTION ACROSS AGE, SEX, AND CELL TYPE	33
6. CONTRIBUTION OF COPY NUMBER VARIANTS TO SCHIZOPHRENIA IN EAST ASIAN POPULATIONS	33